PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 58 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

8 December 2024

  1. (diff | hist) 07:14 Wuhan Wansheng Biotechnology 7,904 +144 CDMO_Caradoc (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  2. (diff | hist) 06:19 Insulin secretion 4,446 +37 Chromatokid (talk | contribs) add the postprandial time course with its units [rollback]
  3. (diff | hist) m 04:57 ISO 9001 2,449 ±0 StateBoardStace (talk | contribs) name the regulator rather than writing "the authorities" [rollback]
  4. (diff | hist) 04:09 Resin cleavage 2,954 +34 ManualOfStyleMo (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]

7 December 2024

  1. (diff | hist) 22:26 Limit of detection 3,547 +38 NNT_Nerys (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  2. (diff | hist) 20:50 Glossary of peptide terminology 3,581 +108 DiagramDelphine (talk | contribs) state the date the list was last reconciled against the articles [rollback]
  3. (diff | hist) m b 17:29 Reverse-phase HPLC 3,884 +142 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  4. (diff | hist) m 17:06 Lixisenatide 2,302 ±0 ComparisonCato (talk | contribs) add the molecular formula to the infobox [rollback]
  5. (diff | hist) m 16:14 VendorInvestigate 3,440 +559 NPOV_Nadia (talk | contribs) convert the service comparison to a table [rollback]
  6. (diff | hist) 16:00 Methionine oxidation 2,318 +246 MolarMassMaeve (talk | contribs) expand §Chemistry and promoters [rollback]
  7. (diff | hist) 15:43 Trifluoroacetate counterion 2,739 ±0 DrTitration (talk | contribs) add the reference standard and its traceability [rollback]
  8. (diff | hist) 11:17 USP General Chapter 71 2,221 +507 AAA_Analyst (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  9. (diff | hist) 11:14 Talk:GL Biochem (Shanghai) 1,033 +181 PuffRemoverPax (talk | contribs) /* Supporter disclosure and article neutrality */ reply
  10. (diff | hist) 10:13 Weight regain after discontinuation 3,536 +597 ToleranceTove (talk | contribs) correct the percentage — source reports it per patient-year [rollback]
  11. (diff | hist) m 05:47 Retatrutide 4,579 +98 ComparisonCato (talk | contribs) expand §Reported clinical findings [rollback]
  12. (diff | hist) m 05:27 Peptide harm reduction 2,056 ±0 CDMO_Caradoc (talk | contribs) de-duplicate a repeated sentence [rollback]
  13. (diff | hist) N 03:46 MOTS-c 2,051 +2,051 AnalyticalAnnie (talk | contribs) start article; sequence and sourcing only so far
  14. (diff | hist) 02:41 TRIUMPH trial programme 2,837 ±0 HOMA_Hettie (talk | contribs) ce, tighten prose [rollback]
  15. (diff | hist) 01:54 Arcuate nucleus 3,033 ±0 LipidLedgerLou (talk | contribs) correct the second-messenger pathway named in the lead [rollback]

6 December 2024

  1. (diff | hist) m b 20:09 Medutest 3,380 +642 CiteBot (talk | contribs) bot: add maintenance category [rollback]
  2. (diff | hist) m b 19:07 Chain of custody 2,966 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) m 18:09 Cagrilintide 2,970 +32 MazdutideMads (talk | contribs) give the strength per pen as well as per millilitre [rollback]
  4. (diff | hist) m 16:41 Counterfeit peptide 1,385 ±0 CommaCarys (talk | contribs) expand §Dilution with bulking agent [rollback]
  5. (diff | hist) 09:36 Talk:GL Biochem (Shanghai) 822 +312 NPOV_Nadia (talk | contribs) /* Supporter disclosure and article neutrality */ reply
  6. (diff | hist) 09:24 Drug master file 2,228 +32 CommaCarys (talk | contribs) ce, tighten prose [rollback]
  7. (diff | hist) 07:24 Baseline laboratory panel 2,337 +33 FerritinFay (talk | contribs) add the units and the conversion factor to SI [rollback]
  8. (diff | hist) m b 06:36 Third-party testing 5,061 +135 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  9. (diff | hist) 06:29 Tirzepatide 5,345 +225 OrforglipronOona (talk | contribs) de-duplicate a repeated sentence [rollback]
  10. (diff | hist) m 04:57 Exenatide 3,389 +454 TimelineTiernan (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  11. (diff | hist) 04:24 Intention-to-treat analysis 3,350 +34 FlowTrialFraser (talk | contribs) the article attributed a finding to the wrong trial in the programme [rollback]

5 December 2024

  1. (diff | hist) 18:52 Cold chain 15,523 ±0 PancreasPru (talk | contribs) add the light-exposure point for photosensitive material [rollback]
  2. (diff | hist) 18:46 Repackaging 2,904 ±0 SPPS_Sorrel (talk | contribs) add category for logistics [rollback]
  3. (diff | hist) 17:40 Peptide aggregation 3,081 ±0 IsocraticIla (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  4. (diff | hist) 13:22 Talk:GL Biochem (Shanghai) 611 +323 CoI_Corin (talk | contribs) /* Supporter disclosure and article neutrality */ reply
  5. (diff | hist) 10:41 Talk:GL Biochem (Shanghai) 400 +547 RfC_Rasmus (talk | contribs) /* Supporter disclosure and article neutrality */ new section
  6. (diff | hist) 10:34 Bacterial endotoxin test 3,947 +1,018 SemaglutideSasha (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  7. (diff | hist) 07:52 USP General Chapter 85 2,668 ±0 SiteReactionSuz (talk | contribs) move a stray full stop inside the reference [rollback]
  8. (diff | hist) 06:51 Reference standard 3,767 +123 Areapercent_Ayo (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  9. (diff | hist) m b 06:40 Fasting insulin 2,254 ±0 StubSorterBot (talk | contribs) bot: normalise unit spacing [rollback]
  10. (diff | hist) 00:54 Placebo-adjusted effect 2,853 ±0 AppendixAlva (talk | contribs) the article attributed a finding to the wrong trial in the programme [rollback]
  11. (diff | hist) 00:13 Sarcopenia 1,597 +424 FlowTrialFraser (talk | contribs) add the sample-stability sentence with its storage condition [rollback]
  12. (diff | hist) m b 00:08 Active pharmaceutical ingredient 1,752 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]

4 December 2024

  1. (diff | hist) m 23:51 Peptide synthesis 3,750 +129 AnalyticalAnnie (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  2. (diff | hist) m 22:15 GLP-1 receptor agonist 8,122 ±0 ExenatideEzra (talk | contribs) fix indentation in the source [rollback]
  3. (diff | hist) m b 17:45 Beta cell function 3,162 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 17:08 Receptor bias 2,387 ±0 Chromatokid (talk | contribs) convert the receptor-distribution list to a table [rollback]
  5. (diff | hist) 15:43 Deamidation 2,345 +38 AnalyticalAnnie (talk | contribs) add category for method validation [rollback]
  6. (diff | hist) m b 15:21 Karl Fischer titration 5,998 +848 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  7. (diff | hist) m 07:39 Personal importation policy 1,572 ±0 LabelLibby (talk | contribs) add the effective date to the regulatory table [rollback]
  8. (diff | hist) m 07:29 Injection site rotation 2,929 ±0 BUD_Bertram (talk | contribs) expand §Rotation schemes [rollback]
  9. (diff | hist) 03:05 Blind sampling 3,929 +202 GroupBuyGalen (talk | contribs) state what the certificate actually carries, field by field [rollback]
  10. (diff | hist) 02:27 Beyond-use date 7,318 +1,188 EndotoxinEd (talk | contribs) clarify which volume the graduation marks measure [rollback]

3 December 2024

  1. (diff | hist) m 22:46 HOMA-IR 2,497 +180 ProglucagonPia (talk | contribs) correct the decimal place in the conversion factor [rollback]
  2. (diff | hist) m 19:47 Regulatory status by jurisdiction 2,139 ±0 MelanocortinMil (talk | contribs) expand §The categories [rollback]
  3. (diff | hist) m 18:12 Dipeptidyl peptidase-4 4,336 +168 GIP_Genoveva (talk | contribs) convert the receptor-distribution list to a table [rollback]
  4. (diff | hist) 15:35 Peptide harm reduction 2,056 +798 CostPerMgCory (talk | contribs) rm the telehealth provider name; the article describes the model, not the vendors [rollback]
  5. (diff | hist) m 10:49 Orforglipron 2,355 +781 RetatrutideRuben (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  6. (diff | hist) N 09:00 Sangon Biotech 1,711 +1,711 SecondarySrc_Seb (talk | contribs) new article: supplier organisation, created after the notability discussion
  7. (diff | hist) m 08:25 Subcutaneous injection 3,730 +40 EscalationEira (talk | contribs) clarify that the figure is per dose, not per vial [rollback]
  8. (diff | hist) m 06:13 Triple agonist 2,546 ±0 ColdChainCleo (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  9. (diff | hist) m 01:20 Fmoc chemistry 3,388 ±0 TierTwoTansy (talk | contribs) fix a broken wikilink [rollback]
  10. (diff | hist) 00:29 Lot traceability 3,642 +848 VerifyVesna (talk | contribs) state what the certificate actually carries, field by field [rollback]

2 December 2024

  1. (diff | hist) 18:54 Vial filling and stoppering 2,748 +268 TirzTaxonomist (talk | contribs) state that overlay gas is used and name it [rollback]
  2. (diff | hist) m 17:59 LEADER trial 2,357 ±0 ShortageShona (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  3. (diff | hist) m 15:43 Peptide 4,033 ±0 SVG_Solomon (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  4. (diff | hist) 15:09 Vial 13,182 +303 PrepHPLC_Pia (talk | contribs) expand §Vials in unregulated distribution [rollback]
  5. (diff | hist) m 10:10 Amylin receptor agonist 2,905 +334 ExenatideEzra (talk | contribs) split overlong sentence [rollback]
  6. (diff | hist) N 09:00 Counterfeit peptide 1,385 +1,385 ForgeryFinder (talk | contribs) start article on the testing subject
  7. (diff | hist) m 07:30 Aspiration risk under anaesthesia 2,915 +269 SurmountSurma (talk | contribs) ce per PP:MOS [rollback]
  8. (diff | hist) m 04:15 Missed dose 3,355 +215 FiveOhThreeB (talk | contribs) add the beyond-use interval with the storage condition it assumes [rollback]
  9. (diff | hist) 02:43 Underfilling 1,727 ±0 ReportReaderRilla (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]

1 December 2024

  1. (diff | hist) 23:07 WuXi TIDES 7,453 +336 LotTraceLuka (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  2. (diff | hist) m 22:28 Glucose-dependent insulinotropic polypeptide 5,577 +118 BacWaterBarnaby (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  3. (diff | hist) 19:47 Survodutide 2,514 ±0 IcodecIndra (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  4. (diff | hist) m 19:30 Good manufacturing practice 2,501 ±0 DrTitration (talk | contribs) attribute the compounding statement to the pharmacy board that issued it [rollback]
  5. (diff | hist) 18:37 Peptide supply chain 3,807 +268 LotTraceLuka (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  6. (diff | hist) m 14:15 ChinaPeptides 3,956 ±0 IcodecIndra (talk | contribs) add category for suppliers in China [rollback]
  7. (diff | hist) 12:22 Melanotan II 1,970 +793 ShortDescShai (talk | contribs) split the pharmacology section from the marketing history [rollback]
  8. (diff | hist) 10:39 Proglucagon 4,138 +673 COA_Colwyn (talk | contribs) add see also to the sister hormone [rollback]
  9. (diff | hist) 06:21 Liraglutide 3,273 ±0 MolarMassMaeve (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  10. (diff | hist) m 04:05 Test report forgery 2,860 +541 LedgerLysander (talk | contribs) expand §Consequences for how documents are used [rollback]
  11. (diff | hist) 01:31 Body composition assessment 1,910 ±0 CoI_Corin (talk | contribs) expand §Lean mass loss during weight reduction [rollback]

30 November 2024

  1. (diff | hist) 21:15 Shanghai Sigma-Audley New Material Technology 2,709 ±0 ForgeryFinder (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) 20:18 Insulin syringe 3,647 +758 VerifyFirstVida (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  3. (diff | hist) 18:25 Certificate of analysis 5,485 ±0 PurityClaimPia (talk | contribs) add the point that reports reaching this wiki are not a sample of anything [rollback]
  4. (diff | hist) m b 15:17 Customs seizure 1,799 ±0 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  5. (diff | hist) 07:03 Dual incretin agonist 4,447 +982 IncretinIvo (talk | contribs) add the molecular formula to the infobox [rollback]
  6. (diff | hist) 04:28 FLOW trial 2,601 ±0 HedgeHedda (talk | contribs) add the number randomised and the number completing [rollback]
  7. (diff | hist) 02:57 Residual solvent 2,880 ±0 TechnicianTeal (talk | contribs) add the cross-link to the compendial chapter [rollback]
  8. (diff | hist) 01:22 Crude peptide 2,632 ±0 FmocFrancis (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  9. (diff | hist) N 01:09 Peptide harm reduction 1,258 +1,258 HarmReductionHen (talk | contribs) create article — access and cost stub

29 November 2024

  1. (diff | hist) 22:08 Nantong Guangyuan Chemical 6,620 +170 VerifyFirstVida (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  2. (diff | hist) m b 21:29 Retention time 2,901 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) m b 21:13 Glucagon-like peptide-1 8,227 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) 14:42 Incretin effect 4,982 ±0 TesamorelinTeg (talk | contribs) add the postprandial time course with its units [rollback]
  5. (diff | hist) 14:27 Analytical method validation 3,011 +32 FootnoteFyfe (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  6. (diff | hist) 14:14 List of GLP-1 receptor agonists 2,606 ±0 RedirectRini (talk | contribs) reconcile the list against the category; two articles were missing [rollback]
  7. (diff | hist) 13:05 Peptide stability table 1,273 ±0 Chromatokid (talk | contribs) add the note that vial overfill is not assumed [rollback]
  8. (diff | hist) 11:18 Area percent purity 3,599 ±0 UnitsUrsula (talk | contribs) add the cross-link to the compendial chapter [rollback]
  9. (diff | hist) 09:52 International nonproprietary name 2,241 +178 CagriCass (talk | contribs) space between number and unit per PP:MOS [rollback]